Treatment of depression in patients with coronary artery disease [4]

JAMA

Volumn 297, Issue 17, 2007, Pages 1878-1879

  Ziegelstein, Roy C ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

CANADA; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DRUG EFFICACY; HUMAN; LETTER; LONG TERM CARE; MAJOR DEPRESSION; MENTAL STRESS; PRIORITY JOURNAL; PSYCHOTHERAPIST; PSYCHOTHERAPY; RISK FACTOR; TREATMENT OUTCOME; UNITED STATES; AGED; CORONARY ARTERY ATHEROSCLEROSIS; MIDDLE AGED; NOTE; PSYCHOLOGICAL ASPECT;

AGED; CITALOPRAM; CORONARY ARTERIOSCLEROSIS; DEPRESSIVE DISORDER, MAJOR; HUMANS; MIDDLE AGED; PSYCHOTHERAPY, BRIEF; SEROTONIN UPTAKE INHIBITORS; SERTRALINE;

EID: 34247849280     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.297.17.1878-b     Document Type: Letter

References (4)

1. Lespérance F, Frasure-Smith N, Koszycki D, et al; CREATE Investigators. Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. JAMA. 2007;297:367-379.
2. Rosamond W, Flegal K, Friday G, et al. Heart disease and stroke statistics - 2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee [published online ahead of print]. Circulation. 2007;115:e69-e171.
3. Reynolds CF, Frank E, Perel JM, et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized controlled trial in patients older than 59 years. JAMA. 1999;281:39-45.
4. Miller MD, Cornes C, Frank E, et al. Interpersonal psychotherapy for late-life depression: past, present, and future. J Psychother Pract Res. 2001;10:231-238.